CPT® Code 90650

The CPT® Code 90650 refers to the Human Papillomavirus (HPV) vaccine, specifically the bivalent formulation that targets types 16 and 18. This vaccine is administered via intramuscular injection and is designed to be given in a three-dose schedule. Vaccines, unlike immune globulins, provide long-term immunity by stimulating the recipient's immune system to recognize and combat specific pathogens. In this case, the HPV vaccine exposes the immune system to an altered version of the virus, prompting the production of antibodies that will protect against future infections. The HPV virus comprises over 100 different types, some of which can lead to benign warts, while others, particularly the high-risk strains, are associated with the development of cervical cancer. The administration of this vaccine is most effective when given before the individual has been exposed to the virus, thereby preventing potential infections and their serious long-term consequences, such as cancer. It is important to note that this code specifically reports the supply of the bivalent vaccine product, distinguishing it from other HPV vaccines such as the quadrivalent (4vHPV) and nonavalent (9vHPV) vaccines, which target additional strains associated with various cancers.